DR Ken Chin

DR Ken Chin




  • Ken is a pharmacist and clinical epidemiologist with a particular interest in heart failure, diabetes, pharmacoepidemiology and health economics. Ken's specific expertise is in large datasets, data linkage and analyses for comparative effectiveness research and HTA. His skills include economic modelling, multiple imputation, propensity score analyses, survival analyses and time series analyses. Ken has a strong track record, with publications in highly ranked journals including The Lancet and European Journal of Heart Failure. In addition, he has disseminated his work at prestigious national and international conferences including the American Heart Association Scientific Sessions. Ken is actively involved in collaborations with industry, especially with regards to development of economic models for PBAC submissions and clinical trials. At Melbourne Medical School, Ken is the subject coordinator of Principles of Clinical Research, Study Design and Advanced Clinical Trials subjects in the Masters of Clinical Research program.   


Member of

  • ANZ Alliance for Cardiovascular Trials (ANZACT) Network. Member 2018 -
  • Heart Failure Society of America. Member 2018 -
  • American Heart Association. Member 2017 -
  • International Society for Pharmacoeconomics and Outcomes Research Australia Chapter. Member 2017 -
  • High Blood Pressure Research Council of Australia. Member 2015 -
  • Board of Pharmacy Specialties, USA. Board Certified Pharmacotherapy Specialist 2012 -


Selected publications


Education and training

  • PhD, Monash University


Available for supervision

  • Y